Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SUH, Cheolwon")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 45

  • Page / 2
Export

Selection :

  • and

Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region : A high rate of dissemination and disease recurrenceSUH, Cheolwon; HUH, Jooryung; ROH, Jong-Lyel et al.Oral oncology (1997). 2008, Vol 44, Num 10, pp 949-955, issn 1368-8375, 7 p.Article

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doubletsDAE HO LEE; KIM, Sang-We; SUH, Cheolwon et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 35-39, issn 0344-5704, 5 p.Article

Prospective randomized comparative observation of single-versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphomaJANG, Geundoo; OCK BAE KO; KIM, Shin et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 4, pp 640-646, issn 0041-1132, 7 p.Article

Leptomeningeal carcinomatosis in gastric cancerLEE, Jae-Lyun; KANG, Yoon-Koo; KIM, Sang-We et al.Journal of neuro-oncology. 2004, Vol 66, Num 1-2, pp 167-174, issn 0167-594X, 8 p.Article

High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphomaPARK, Kwonoh; DOK HYUN YOON; KIM, Shin et al.International journal of hematology. 2013, Vol 97, Num 2, pp 256-262, issn 0925-5710, 7 p.Article

Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrowWON, Dahae; PARK, Chan-Jeoung; SHIM, Hyoeun et al.Histopathology. 2013, Vol 62, Num 3, pp 397-405, issn 0309-0167, 9 p.Article

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the LungHAN, Ji-Youn; PARK, Keunchil; LEE, Jung-Shin et al.Journal of clinical oncology. 2012, Vol 30, Num 10, pp 1122-1128, issn 0732-183X, 7 p.Article

The Survivin Suppressant YM155 Potentiates Chemosensitivity to Gemcitabine in the Human Pancreatic Cancer Cell Line MiaPaCa-2DOK HYUN YOON; SHIN, Jae-Sik; JUNG SHIN LEE et al.Anticancer research. 2012, Vol 32, Num 5, pp 1681-1688, issn 0250-7005, 8 p., aArticle

Expression of JL1 in Burkitt lymphoma is associated with improved overall survivalHWANG, Ilseon; GO, Heounjeong; YOON KYUNG JEON et al.Virchows Archiv. 2011, Vol 459, Num 4, pp 353-359, issn 0945-6317, 7 p.Article

Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas : a comparison with ESHAPMIN KYOUNG KIM; SHIN KIM; SUH, Cheolwon et al.Transfusion (Philadelphia, PA). 2007, Vol 47, Num 8, pp 1447-1454, issn 0041-1132, 8 p.Article

Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphomaYOO, Changhoon; DOK HYUN YOON; SUH, Cheolwon et al.International journal of hematology. 2013, Vol 97, Num 2, pp 232-239, issn 0925-5710, 8 p.Article

Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II StudyDAE RO CHOI; DAE HO LEE; CHOI, Chang-Min et al.Anticancer research. 2011, Vol 31, Num 10, pp 3457-3462, issn 0250-7005, 6 p.Article

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group StudyYAMAGUCHI, Motoko; KWONG, Yok-Lam; SUZUMIYA, Junji et al.Journal of clinical oncology. 2011, Vol 29, Num 33, pp 4410-4416, issn 0732-183X, 7 p.Article

Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma studySUNG YONG OH; WON SEOG KIM; YEE SOO CHAE et al.International journal of hematology. 2010, Vol 92, Num 3, pp 510-517, issn 0925-5710, 8 p.Article

[18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung. CommentaryMANKOFF, David A; EARY, Janet F; LEE, Jung-Shin et al.Clinical cancer research (Print). 2008, Vol 14, Num 22, issn 1078-0432, 7159-7160, 7423-7429 [9 p.]Article

Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-typeLEE, Jeeyun; SUH, Cheolwon; HUH, Jooryung et al.Clinical cancer research. 2007, Vol 13, Num 11, pp 3250-3254, issn 1078-0432, 5 p.Article

Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaOHMACHI, Ken; NIITSU, Nozomi; TERAUCHI, Takashi et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2103-2109, issn 0732-183X, 7 p.Article

Prognostic Significance of the Ratio of Absolute Neutrophil Count to Absolute Lymphocyte Count in Classic Hodgkin LymphomaYOUNG WHA KOH; HYO JEONG KANG; PARK, Chansik et al.American journal of clinical pathology. 2012, Vol 138, Num 6, pp 846-854, issn 0002-9173, 9 p.Article

Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) studySUNG YONG OH; WON SEOG KIM; YEE SOO CHAE et al.Cancer science. 2010, Vol 101, Num 11, pp 2443-2447, issn 1347-9032, 5 p.Article

A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphomaSUN JIN SYM; DAE HO LEE; HYE JIN KANG et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 1, pp 27-33, issn 0344-5704, 7 p.Article

Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trialAHN, Myung-Ju; CHOI, Jung-Hye; JUNG, Cheol-Won et al.International journal of hematology. 2003, Vol 78, Num 2, pp 133-138, issn 0925-5710, 6 p.Article

Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for stage III locally advanced, unresectable, non-small-cell lung cancerLEE, Sang-Wook; EUN KYUNG CHOI; YOUNG JU NOH et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 4, pp 996-1004, issn 0360-3016, 9 p.Article

Correlation of hematopoietic progenitor cell count determined by the SE-9000automated hematology analyzer with CD34+cell count by flow cytometry in leukapheresis productsKEON UK PARK; SANG HEE KIM; PARK, Jinny et al.American journal of hematology. 2001, Vol 67, Num 1, pp 42-47, issn 0361-8609Article

Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: A multicentre, single-arm, phase 2 trialSEOK JIN KIM; DOK HYUN YOON; WOO ICK YANG et al.European journal of cancer (1990). 2012, Vol 48, Num 17, pp 3223-3231, issn 0959-8049, 9 p.Article

Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapyYHIM, Ho-Young; JIN SEOK KIM; SHIM, Hyeok et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 235-243, issn 0020-7136, 9 p.Article

  • Page / 2